188.36EUR+0.29%Mkt Cap: 30.25B $P/E: 38.761d ago
Biogen Inc. discovers, develops, manufactures, and delivers therapies in the United States, Europe, Germany, Asia, and internationally. The company provides TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, and TYSABRI for multiple…
Industry Peers
Drug Manufacturers - General$1.14TUSDP/E 43.0
$658.89BUSDP/E 31.7
$462.68BUSDP/E 74.0
$375.50BUSDP/E 122.7
$341.92BUSDP/E 24.5
$279.13BUSDP/E 22.3
$274.07BUSDP/E 23.6
$240.45BUSDP/E 24.5
$231.49BUSDP/E 24.5
$238.75BUSDP/E 27.4
$190.75BUSDP/E 11.3
$183.02BUSD
$160.96BUSDP/E 37.2
$138.11BUSDP/E 14.9
$101.30BUSDP/E 24.0
$98.67BUSDP/E 16.3
$51.91BUSD
$32.74BUSDP/E 39.4
MRV
Marvell Technology, Inc.$26.57BUSDP/E 10.1
$12.10BUSDP/E 18.9
Key Statistics
Company
Market Cap30.25B $
Enterprise Value37.23B $
Revenue (TTM)10.90B $
Gross Profit8.14B $
Net Income (TTM)1.41B $
Revenue/Share74.12 USD
Last Price188.36 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees7.5K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISINUS09062X1037
Valuation
P/E (Trailing)38.76
P/E (Forward)—
PEG5.03
EV/EBITDA10.20
EV/Revenue3.42
P/S2.71
P/B1.67
EPS (TTM)4.87
EPS (Forward)—
52W Range
177.9694% of range189.08
52W High189.08 EUR
52W Low177.96 EUR
Profitability
Gross Margin75.69%
Oper. Margin25.06%
EBITDA Margin33.50%
Profit Margin13.07%
ROE7.08%
ROA4.39%
Growth
Revenue Growth3.40%
Earnings Growth-84.80%
Cash Flow & Leverage
Operating CF2.40B $
CapEx (TTM)255.87M $
FCF Margin12.63%
FCF Yield4.55%
Net Debt7.68B $
Net Debt/EBITDA2.10
Balance Sheet
Debt/Equity0.36
Current Ratio1.86
Quick Ratio0.94
Book Value/Sh110.26 EUR
Cash/Share8.697 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.147.75M
Float147.22M
Insiders0.19%
Institutions99.57%
Technical
SMA 50172.86 (+9.0%)
SMA 200155.25 (+21.3%)
Beta0.16
S&P 52W Chg20.80%
Avg Vol (30d)163
Avg Vol (10d)74
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—